Skip to content
healthcare.dev

Mirtazapine

NDC 57237-013, Mirtazapine, tablet, orally disintegrating, from Rising Pharma Holdings, Inc..

Product NDC
57237-013
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077376
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRTAZAPINE45 mg/1
Package NDCNDC-11Package
57237-013-06572370013065 BLISTER PACK in 1 CARTON (57237-013-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/73b7bbd9-7dba-4559-890f-3f8dd821e215
  • NADAC price for package 57237001306

    GET /v1/drugs/nadac/57237001306

Use it

Look up 57237-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.